Recce Pharmaceuticals raises $15.8 million to advance its Phase 3 trials for its topical gel treatment in Indonesia and Australia. Recce's raised $7.4 million in an entitlement offer shortfall ...

Recce's raised $7.4 million in an entitlement offer shortfall, the final part of a broader $15.8 million capital raising effort. Funds raised will be used to support Recce's Phase 3 clinical ...

Recce receives firm commitments to place the full shortfall from its entitlement offer raising a total of $15.8 million to support phase III clinical trials. Don't miss out on the headlines from ...

Recce Pharmaceuticals secures patent acceptance in China for synthetic anti-infectives as it targets growing global health problem of antibiotic-resistant superbugs. Acceptance strengthens the ...

Special Report: Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives RECCE® 327 (R327) and RECCE® 529 (R529) as it targets the growing global health ...

BENSONHURST — After nearly 60 years, a Bensonhurst staple is saying goodbye. SAS Italian Records, 7113 18th Ave., will be permanently closing its doors. The news was announced by Antonio ...

At its Innovate conference, SAS on Wednesday announced a series of offerings across its portfolio that focus on AI in all its forms. They ranged from a series of enhancements to its Viya platform ...

AN SAS war hero has attacked Sir Keir Starmer for betraying Britain’s veterans – on the 80th anniversary of VE Day. Falklands War legend Aldwin Wight, who led 22 SAS regiment, led a surprise ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Recce Pharmaceuticals (ASX:RCE)has partnered with the US Army Medical Research Institute of Infectious ...

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today announced ...